Clin Res Cardiol 100, Suppl 1, April 2011

P398 - Benefits of intensified telemedical care for patients with heart failure - Outcomes of a naturalistic study in certain regions of Germany
F. Zucca1, C. Novakovic2, H. Palisch3, B. Neukirch2, M. Rauchhaus4
1SHL Telemedizin, Düsseldorf; 2Hochschule Niederrhein, Krefeld; 3Krankenhaus Dresden-Friedrichstadt, Dresden; 4Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin;
Purpose: Home care telemonitoring under usual care conditions has been reported to reduce the burden of morbidity in patients with heart failure, although randomised controlled trials did not. We investigated whether intensified telemedical care provides timely interventions, reduces hospital readmissions and days in hospital as well as saves hospital costs in patients with heart failure, based on analyses of routine data of a big health insurance company in Germany.
Methods: A total of 2,182 patients with at least one hospitalization due to heart failure within the last twelve months were evaluated. 425 patients were enrolled prospectively in a staged telemedical service program. They received, in addition to usual care, telemonitoring equipment and were asked to transmit body weight, blood pressure and pulse rate daily to a telemedical service center. Patients were also encouraged to transmit a 12-lead ECG on demand. 1,757 controls were matched 4:1 to each telemedicine patient according to age, gender and heart failure etiology.
Results: After follow-up of 12 months, 155 telemedicine patients (37 %) were admitted to the hospital 258 times for various indications. The mean stay in hospital were 4 ± 8 days per patient. Within the control group, 1,187 patients (68 %) were hospitalized 2,892 for various indications. These patients had a mean stay in hospital of 14 ± 21 days. Hospital admissions and hospital days per year and patients were significantly lower in the intervention group (both p<0.0001). Hospital costs for one year were significantly lower (-75 %) in the intervention group compared with the control group (1,532 € ± 3,229 € vs. 6,126 € ± 8,697 €; p<0.0001).
Conclusion: Findings of this analysis suggest that telemedical care and telemonitoring may improve CHF patients’ morbidity, thereby increasing quality of life while saving hospital costs.
Clin Res Cardiol 100, Suppl 1, April 2011
Zitierung mit Vortrags- oder Posternummer s.o.
DOI 10.1007/s00392-011-1100-y